Demonstration and Diagnostic Significance of Pro-Gastrin-Releasing Peptide in Medullary Thyroid Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|59|2|122-125

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.2, 2000-08, pp. : 122-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of binding sites for C‐terminal pro‐gastrin‐releasing peptide (GRP)‐derived peptides in renal cell carcinoma: a potential target for future therapy

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 829-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

Medullary Thyroid Carcinoma

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 334-337

Karger

Access to resources Recommend Favorite

Gastrin-Releasing Peptide Receptor Expression in Cervical Cancer

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 340-345

Karger

Access to resources Recommend Favorite

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite